Breaking News Instant updates and real-time market news.

AAPL

Apple

$168.38

-4.42 (-2.56%)

, FB

Facebook

$157.20

-2.14 (-1.34%)

07:51
04/09/18
04/09
07:51
04/09/18
07:51

Apple co-founder Steve Wozniak leaving Facebook, USA Today reports

Apple (AAPL) co-founder Steve Wozniak tells USA Today that he is leaving Facebook (FB), saying ""Users provide every detail of their life to Facebook and... Facebook makes a lot of advertising money off this... The profits are all based on the user's info, but the users get none of the profits back." Commenting on Apple, Wozniak said "Apple makes its money off of good products, not off of you," adding that "As they say, with Facebook, you are the product." Reference Link

AAPL

Apple

$168.38

-4.42 (-2.56%)

FB

Facebook

$157.20

-2.14 (-1.34%)

  • 09

    Apr

  • 10

    Apr

  • 10

    Apr

  • 11

    Apr

  • 11

    Apr

  • 17

    Apr

  • 25

    Apr

AAPL Apple
$168.38

-4.42 (-2.56%)

04/05/18
SBSH
04/05/18
NO CHANGE
Target $200
SBSH
Buy
Citi sees $100B opportunity in Apple's capital returns strategy
Citi analyst Jim Suva reiterates a Buy rating on Apple shares with a $200 price target. The analyst expects "volatility ahead" for the stock as consensus estimates for the March and June quarters move lower to reflect more tempered demand for the iPhone X. Looking ahead, however, Suva expects investor focus to be on the impact from Apple's capital returns strategy. He estimates this could be a $100B increase. Investors will also soon focus on Apple's second half of 2018 product lineup and continued strength in its Services segment, Suva tells investors in a research note.
04/04/18
BERN
04/04/18
NO CHANGE
BERN
Market Perform
Narrowing gap between TSMC, Intel makes Apple's aspiration possible, says Bernstein
Bernstein analyst Mark Li believes that given Apple's (AAPL) experience in processor design, replacing Intel (INTC) processor with its own is possible. Further, the analyst says that the narrowing gap in process technology between TSMC (TSM) and Intel also makes Apple's aspiration possible, while Apple's vertical integration with OS and applications also puts it in a better position to challenge Intel. Li sees a downside to TSMC's 2019 revenue because of Bitcoin, but says it remains a "solid" company with balanced risk and reward. The analyst reiterates a Market-Perform rating on TSMC shares.
04/03/18
MSCO
04/03/18
NO CHANGE
Target $43
MSCO
Equal Weight
Intel has limited risk from 'recurring' Apple concerns, says Morgan Stanley
After Bloomberg reported yesterday that Apple (AAPL) is evaluating using its own processors in Mac computers, Morgan Stanley analyst Joseph Moore noted that this has been a recurring concern in recent years for Intel (INTC). Ensuring backwards compatibility with prior Macs would require emulation, which could be problematic for Apple given that ARM processors have lower performance for most common PC applications, said Moore. The analyst, who doesn't see Intel's roughly 4% exposure to Macs being fully at risk, maintains his Equal Weight rating on Intel shares.
04/03/18
RBCM
04/03/18
NO CHANGE
Target $46
RBCM
Sector Perform
Apple's chip insourcing to have modest impact on Intel, says RBC Capital
RBC Capital analyst Amit Daryanani writes that yesterday's Bloomberg report about Apple's (AAPL) plans to replace Intel (INTC) x86 processor solutions in its Mac product line is likely to have a "modest" impact of annual 20c-25c EPS and $3B-$4B on Intel over longer term. Daryanani believes that the initiative is still at an early stage and his assumption accounts for a total loss of Apple's processor allocation, though he also warns that Apple's insourcing could create a business impact on the broader supply chain. The analyst keeps his Sector Perform rating and $46 price target on Intel, maintaining a neutral stance on the possibility of heightened competition from AMD's (AMD) Epyc processor.
FB Facebook
$157.20

-2.14 (-1.34%)

04/05/18
WELS
04/05/18
NO CHANGE
Target $230
WELS
Outperform
Facebook expected to 'weather the storm,' says Wells Fargo
Wells Fargo analyst Ken Sena says his advertising and agency contacts continue to point to the fact that marketers with direct and purchased access to third party data will still be able to apply it to Facebook targeting. Moreover, combined with the fact that Facebook's first party data and advertiser's customer data will continue to be applicable to Facebook targeting, the analyst expects no material negative impact on advertiser spending. Sena reiterates an Outperform rating and $230 price target on the shares.
04/04/18
SPHN
04/04/18
NO CHANGE
Target $32
SPHN
Overweight
Acxiom overreaction to Facebook news a buying opportunity, says Stephens
Stephens analyst Brett Huff noted that Acxiom (ACXM) CEO Scott Howe published a blog post stating that he has seen "some signs" that Facebook (FB) is reconsidering its new policy on data imports in light of advertiser concerns. Huff, who thinks the blog post is a potential indication of the level of concern advertisers are having about Facebook's recent move, remains a buyer of Acxiom shares as he views the recent negative stock reaction to Facebook's news as overdone. He maintains his $32 price target and Overweight rating on Acxiom shares.
04/04/18
SBSH
04/04/18
NO CHANGE
SBSH
Buy
Facebook pullback brings long-term opportunity, says Citi
Citi analyst Mark May believes the recent selloff in shares of Facebook brings an opportunity for long-term minded investors. The analyst, however, believes the company's current situation is "difficult to quantify" and he expects near-term volatility to persist. May maintains a Buy rating on Facebook.
04/04/18
MSCO
04/04/18
NO CHANGE
Target $200
MSCO
Overweight
Morgan Stanley still bullish on Facebook, but trims target to $200
After having spoken with eight agencies/advertisers about Facebook following the company's recent data and privacy issues and its announcement that it will end partnerships with third party data providers, Morgan Stanley analyst Brian Nowak said he did not sense any material reduction in ad spend. He actually thinks the elimination of third parties is smart strategically over the long-term, as he sees it highlighting Facebook's leading reach and first party data advantage. While he noted his agency conversations were positive, Nowak also acknowledged his sample "is far from statistically significant." Feeling it appropriate to be more conservative in the near-term, he lowered his 2018 and 2019 ad revenue estimates for Facebook by 2% and 3%, respectively, and cut his price target to $200 from $230, also citing increased expectations for investment in data safety. Nowak, who said he is still bullish on Facebook, keeps an Overweight rating on the name.

TODAY'S FREE FLY STORIES

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:55
08/14/18
08/14
16:55
08/14/18
16:55
Hot Stocks
LRAD Corporation says 'well positioned to achieve record fiscal year revenues' »

"LRAD is in a much…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:54
08/14/18
08/14
16:54
08/14/18
16:54
Hot Stocks
Breaking Hot Stocks news story on LRAD Corporation »

LRAD Corporation reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

LRAD

LRAD Corporation

$2.83

0.02 (0.71%)

16:53
08/14/18
08/14
16:53
08/14/18
16:53
Earnings
LRAD Corporation reports Q3 EPS 0c, one estimate 0c »

Reports Q3 revenue $7.5M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 23

    Aug

CDNA

CareDx

$16.87

-0.13 (-0.76%)

16:50
08/14/18
08/14
16:50
08/14/18
16:50
Hot Stocks
CareDx CFO Michael Brian Bell sells 12,500 shares of company stock »

CareDx CFO Michael Brian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

VNDA

Vanda Pharmaceuticals

$21.60

0.15 (0.70%)

16:46
08/14/18
08/14
16:46
08/14/18
16:46
Hot Stocks
Vanda Pharmaceuticals wins denial of petition for rehearing on Fanapt »

Vanda Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$193.08

-1.03 (-0.53%)

16:45
08/14/18
08/14
16:45
08/14/18
16:45
Recommendations
Home Depot analyst commentary  »

Home Depot underlying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FANG

Diamondback Energy

$133.75

1.84 (1.39%)

16:45
08/14/18
08/14
16:45
08/14/18
16:45
Hot Stocks
Breaking Hot Stocks news story on Diamondback Energy »

Diamondback Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOW

Lowe's

$98.41

1.32 (1.36%)

, UTX

United Technologies

$132.40

0.23 (0.17%)

16:42
08/14/18
08/14
16:42
08/14/18
16:42
Hot Stocks
Pershing Square adds Lowe's, cuts stake in ADP »

Bill Ackman's…

LOW

Lowe's

$98.41

1.32 (1.36%)

UTX

United Technologies

$132.40

0.23 (0.17%)

MDLZ

Mondelez

$41.87

-0.03 (-0.07%)

ADP

ADP

$141.17

1.48 (1.06%)

QSR

Restaurant Brands

$62.20

0.355 (0.57%)

CMG

Chipotle

$493.33

8.97 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 22

    Aug

  • 07

    Sep

  • 11

    Sep

  • 12

    Sep

  • 24

    Sep

DXC

DXC Technology

$86.56

2.02 (2.39%)

16:41
08/14/18
08/14
16:41
08/14/18
16:41
Hot Stocks
DXC Technology awarded $400M contract by Wisconsin DHS »

The Wisconsin Department…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

16:39
08/14/18
08/14
16:39
08/14/18
16:39
General news
API crude inventories for week of August 10 »

API reports that crude…

CSOD

Cornerstone OnDemand

$52.59

0.48 (0.92%)

16:35
08/14/18
08/14
16:35
08/14/18
16:35
Recommendations
Cornerstone OnDemand analyst commentary  »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 20

    Aug

  • 21

    Aug

  • 21

    Aug

  • 22

    Aug

  • 27

    Aug

  • 28

    Aug

  • 29

    Aug

  • 04

    Sep

  • 06

    Sep

  • 07

    Sep

  • 12

    Sep

  • 12

    Sep

ATNM

Actinium Pharmaceuticals

$0.62

0.003 (0.49%)

16:34
08/14/18
08/14
16:34
08/14/18
16:34
Conference/Events
Actinium Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 04

    Sep

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

16:34
08/14/18
08/14
16:34
08/14/18
16:34
Earnings
Perspecta sees FY18 pro forma revenue $4.150B-$4.250B, consensus $4.2B »

Sees FY19 adjusted EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

FCN

FTI Consulting

$80.32

0.33 (0.41%)

16:33
08/14/18
08/14
16:33
08/14/18
16:33
Syndicate
Breaking Syndicate news story on FTI Consulting »

FTI Consulting files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRSP

Perspecta

$21.64

-0.31 (-1.41%)

16:32
08/14/18
08/14
16:32
08/14/18
16:32
Hot Stocks
Perspecta reports Q1 adjusted EPS 54c, consensus 46c »

Reports Q1 revenue $793M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

SBBP

Strongbridge Biopharma

$6.25

0.3 (5.04%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Syndicate
Strongbridge Biopharma files to sell 9M ordinary shares »

Cowen and Stifel are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWC

Hancock Whitney

$51.40

0.6 (1.18%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Hancock Whitney names Christopher Ziluca as new Chief Credit Officer »

Hancock Whitney has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRI

Atrion

$656.00

9 (1.39%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Atrion increases quarterly cash dividend by 13% »

Atrion Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TIK

Tel-Instrument

$2.60

(0.00%)

16:31
08/14/18
08/14
16:31
08/14/18
16:31
Hot Stocks
Tel-Instrument receives NYSE non-compliance letter »

Tel Instrument…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/14/18
08/14
16:30
08/14/18
16:30
Options
Preliminary option volume of 16.1M today »

Preliminary option volume…

DLPN

Dolphin Entertainment

$2.96

(0.00%)

16:29
08/14/18
08/14
16:29
08/14/18
16:29
Earnings
Dolphin Entertainment reports Q2 EPS (1c), consensus 2c »

Reports Q2 revenue $5.2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

BK

BNY Mellon

$50.97

0.825 (1.65%)

, GE

General Electric

$12.35

-0.09 (-0.72%)

16:29
08/14/18
08/14
16:29
08/14/18
16:29
Hot Stocks
Trian Fund boosts BNY Mellon, lowers stake in Wendy's »

Nelson Peltz's Trian…

BK

BNY Mellon

$50.97

0.825 (1.65%)

GE

General Electric

$12.35

-0.09 (-0.72%)

MDLZ

Mondelez

$41.87

-0.03 (-0.07%)

WEN

Wendy's

$17.84

0.48 (2.77%)

SYY

Sysco

$74.19

1.47 (2.02%)

PG

Procter & Gamble

$81.31

-0.21 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 07

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

VRAY

ViewRay

$9.89

-0.01 (-0.10%)

16:28
08/14/18
08/14
16:28
08/14/18
16:28
Syndicate
ViewRay files to sell $125M of common stock »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

LMB

Limbach Holding

$10.70

0.11 (1.04%)

16:26
08/14/18
08/14
16:26
08/14/18
16:26
Earnings
Limbach Holding raises FY18 revenue view to $530-$550M from $520M-$540M »

Consensus $527.77M. Now…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

MRSN

Mersana Therapeutics

$12.75

0.04 (0.31%)

16:26
08/14/18
08/14
16:26
08/14/18
16:26
Earnings
Mersana Therapeutics reports Q2 EPS (54c), consensus (58c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 15

    Aug

  • 04

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.